Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • candida utilis
    Junior Member
    • May 2017
    • 6

    #1

    SMART Seq v2: RNA amount and cycles for preampfification

    Hi all,
    We aim to compare differential mRNA expression between 2 different cell types. We sorted 2 populations of cells by FACS, extract RNA by column based methods, and SMARTSEQ v2 for pre-amplificaiton of cDNA.

    Between those cell types, A has very low cell number (150-500 cells). In contrast, B has higher cell number (50,000 cells) but its RNA amount is less. So, I only do RNA quantification for B, because RNA amount in A is too low to be detected by Ribogreen.

    For Pre amplification of cDNA, I have some questions:

    (1) If the starting RNA amount used for SMARTSeq V2 is different between samples, will it affect the RNA Seq results, if we aim to compare the differential mRNA expression between those samples?

    (2) For the pre-amplification of cDNA, will the number of PCR cycles for A and B need to be the same, if I would like to compare the differential mRNA expression between those cell types? If sample A need 20 cycles to get sufficient cDNA, while sample B only need 15 cycles, what should I do? Thank you

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Working...